Journal ArticleOPEN ACCESS

Stereotactic body radiation therapy for the primary treatment of localized prostate cancer

  • Oliai C
  • Lanciano R
  • Sprandio B
  • et al.
Journal of Radiation Oncology (2013) 2(1) 63-70
DOI: 10.1007/s13566-012-0067-2
N/ACitations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The low alpha/beta ratio of prostate cancer suggests that hypofractionated schemes of dose-escalated radiotherapy should be advantageous. We report our experience using stereotactic body radiation therapy (SBRT) for the primary treatment of prostate cancer to assess efficacy and toxicity.

Cite

CITATION STYLE

APA

Oliai, C., Lanciano, R., Sprandio, B., Yang, J., Lamond, J., Arrigo, S., … Brady, L. W. (2013). Stereotactic body radiation therapy for the primary treatment of localized prostate cancer. Journal of Radiation Oncology, 2(1), 63–70. https://doi.org/10.1007/s13566-012-0067-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free